References
- Physiol. Chem. Phys v.5 Biologically active peptides in human urine1. Isolation of a group of medium-sized peptides Burzynski,S.R.
- Fed. Proc. v.32 Effect of urinary peptides on DNA, RNA and protein synthesis in normal and neoplastic cells Burzynski,S.R.;Georgiades,J.
- Physiol. Chem. Phys. v.8 Antineoplastons: Biochemical defense against cancer Burzyski,S.R.
- Proc. 13th Intil. Cong. Chemother(Vienna) v.17 Purification, structure determination, synthesis and animal toxicity studies of antineoplaston A10 Burzynski,S.R.;Hendry,L.B.;Mohabbat,M.O.;Liau,M.C.;Khalid,M.;Burzynski,B.
- Drug Exp. Clin. Res. v.10 Toxicology studies of oral formulation of antineoplaston A10 in cancer patients Burzynski,S.R.;Mohabbat,M.O.;Burzynski,B.
- Drugs of the future v.11 Antineoplaston AS2-1 Burzynski,S.R.
- Drugs of the future v.11 Synthetic antineoplastons and analogs Burzynski,S.R.
- U.S. Patent 4,918,193 Methods for preparing 3-[N-Phenyl-acetylaminopiperidine]-2,6-dione Burzyski,S.R.
- U.S. Patent 5,089,508 Substituted piperidnediones, substituted phenylacetic acids, and substututed phenylacetyl-glutamines for treatment of AIDS Burzyski,S.R.
- Appl. Wo 9204,043 Urine peptides for the treatment of Parkinson's disease Burzyski,S.R.
- U.S. Patent 4,705,796 Use of 3-N-phenlacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorsers Hendry,L.B.;Diamond,A.H.;Diamond,B.I.;Ewing,D.E.
- Appl. WO 91 16,309;US Appl. 508,839 Preparation of 3-phenylacetaminopiperidind-2,6-diones as cytocytic agents Hendry,L.B.;Chu,C.K.;Mahesh,V.B.
- Chem, Pharm, Bull. v.37 no.11 Synthesis and antitumor properties of N¹-acyloxymethyl derivatives of bis(2,6-dioxopiperazines) Jun,C.C.;Han,L.S.;Cai,F.T.;Toshihito,K.;Toshoyuki,M.;Toshiharu,N.
- Archiv der Pharmazie Potentiellecytostatica durch aminomethylierung NH-acides hypnotika Werner,W.;Fritzsche.
- Pharmaceutical Industry v.19 no.5 Improved preparation of antitumor agent antineoplaston A10 Xu Wenfang.;Zhao Yulan.;Yuan Yumei.;Yu YongHui.;